{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:06:27Z","timestamp":1648825587819},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,9,1]]},"DOI":"10.1001\/jamaneurol.2021.2492","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T16:10:54Z","timestamp":1627920654000},"page":"1153","source":"Crossref","is-referenced-by-count":0,"title":["Adequate Initial Dosage and Tapering Methods of Steroids to Reduce the Total Corticosteroid Dose in Myasthenia Gravis"],"prefix":"10.1001","volume":"78","author":[{"given":"Hiroyuki","family":"Akamine","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"nle210007r1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1001\/jamaneurol.2020.5407","article-title":"Comparison of corticosteroid tapering regimens in myasthenia gravis: a randomized clinical trial.","volume":"78","author":"Sharshar","year":"2021","journal-title":"JAMA Neurol"},{"key":"nle210007r2","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-10264-0","article-title":"Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? a systematic review.","author":"Lotan","year":"2020","journal-title":"J Neurol"},{"key":"nle210007r3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jns.2018.10.018","article-title":"Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis.","volume":"396","author":"Kanai","year":"2019","journal-title":"J Neurol Sci"},{"issue":"12","key":"nle210007r4","doi-asserted-by":"publisher","first-page":"e1617","DOI":"10.1212\/WNL.0000000000010574","article-title":"Patient-acceptable symptom states in myasthenia gravis.","volume":"95","author":"Mendoza","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"nle210007r5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/mus.23398","article-title":"The MG-QOL15 Japanese version: validation and associations with clinical factors.","volume":"46","author":"Masuda","year":"2012","journal-title":"Muscle Nerve"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2782753\/jamaneurology_akamine_2021_le_210007_1630683457.065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T15:07:25Z","timestamp":1631200045000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2782753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.2492","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,1]]}}}